NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1041200085

Registered date:25/12/2020

Analysis of Liposomal irinotecan's pharmacokinetics and side effects

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedPancreatic cancer
Date of first enrollment25/12/2020
Target sample size15
Countries of recruitment
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeComparison of drug concentration of Irinotecan and its metabolites by UGT1A1 gene polymorphism
Secondary OutcomeSecondary Outcome(s)Adverse events, Time to treatment failure, Effectiveness (Response rate, progression-free survival, Overall survival)

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximumNot applicable
GenderBoth
Include criteriaPancreatic cancer, underwent UGT1A1 polymorphism test
Exclude criteriaAlready used Onivyde(Liposomal irinotecan)

Related Information

Contact

Public contact
Name Satoshi FURUNE
Address 65 Tsurumai-cho Showa-ku,Nagoya, Aichi Aichi Japan 466-0065
Telephone +81-527442172
E-mail s-furune@med.nagoya-u.ac.jp
Affiliation Nagoya University Hospital
Scientific contact
Name Yuichi ANDO
Address 65 Tsurumai-cho Showa-ku,Nagoya, Aichi Aichi Japan 466-0065
Telephone +81-527442172
E-mail yando@med.nagoya-u.ac.jp
Affiliation Nagoya University Hospital